Ventilator change in children on home mechanical ventilation affected by the Philips respironics trilogy ventilator recall.
Heather BrandtDawn M SimonAjay S KasiPublished in: Pediatric pulmonology (2021)
The Philips Respironics recall notification issued in June 2021 affected many of their positive airway pressure devices and mechanical ventilators including the Trilogy 100 and 200 ventilators that are often utilized in children using home positive pressure ventilation via tracheostomy (PPV-T). Optimal strategies to replace ventilators in children using home PPV-T affected by the Philips recall are unknown. We conducted a retrospective study of children using home PPV-T with recalled Trilogy ventilators who underwent inpatient ventilator change to non-recalled portable home ventilators (PHV) using our collaborative institutional protocol. During the study period, there were 40 children using PPV-T with recalled Trilogy ventilators and 19 patients underwent inpatient ventilator change either during an elective hospitalization (n = 8) or during an unscheduled or postoperative hospitalization (n = 11). The median duration of hospitalization for ventilator change was 2 days (interquartile range: 6 days) and generally 1 day for patients admitted solely for ventilator change. In children using PPV-T with recalled Trilogy ventilators, a systematic protocol collaborating with the patients, physicians, and durable medical equipment companies may optimize transition to nonrecalled PHVs.
Keyphrases
- mechanical ventilation
- acute respiratory distress syndrome
- young adults
- healthcare
- end stage renal disease
- intensive care unit
- randomized controlled trial
- newly diagnosed
- ejection fraction
- primary care
- patients undergoing
- respiratory failure
- chronic kidney disease
- obstructive sleep apnea
- palliative care
- peritoneal dialysis
- extracorporeal membrane oxygenation